Drawing for CURASOMA

USPTO serial 87742527

CURASOMA

Reviewed by CopyMark Law Group

Reg. 6044881Status 700Registered
Filing date
Status date
Registration date
May 5, 2020
Examiner
BUTLER, MIDGE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CURASOMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Steve Zemanick

Steve Zemanick Four Reasons Legal8074 E 34th AveDenver, CO 80238UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Enzymes for use as an antioxidant; magnesium carbonate; magnesium hydroxide; calcium; calcium carbonate; calcium salts; magnesium salts; alkaline-earth metals; salts of alkaline metals; potassium; sodium bicarbonate; citric acid; fatty acids for use in preparations of vitamin, mineral, herbal, homeopathic supplements; formic acid; lactic acid; litmus paper; selenium; boron; diatom earth in the nature of diatomite; diatomaceous earth in the nature of diatomite; magnesium oxide; bentonite; calcium chloride; chromium chloride; chromium oxide; chromium oxides; copper sulphate; iron salts; magnesium chloride; manganese carbonate; manganese chloride; phosphorus; potassium hydroxide; sodium; sodium chloride; sodium molybdate; sodium tetraborate; tea extracts for the food industry; trypsin; zinc chloride; magnesium citrate, magneisum chloride, zinc citrate, zinc chloride metal salts of acidsACTIVE—
005Multi-vitamin preparations; vitamin A preparations; vitamin and mineral preparations for medical use; vitamin B preparations; vitamin C preparations; vitamin D preparations; vitamin preparations; vitamin supplements; vitamin tablets; vitamins; vitamins and vitamin preparations; botanical supplements for general health and well-being; botanical extracts for the treatment of colds and flu; botanical extracts for the treatment of inflammatory bowel disease and connective tissue diseases; botanical extracts for the treatment of stomach ulcers; herbal and dietary supplements for promoting faster muscle recovery after exercise; herbal supplements for general health and well-being; herbal supplements for the promotion of healthy liver function; herbal supplements for the treatment of cardiovascular diseases; herbal supplements for the treatment of headaches; herbal supplements for the treatment of inflammatory diseases, namely, inflammatory bowel diseases and inflammatory connective tissue diseases; herbal supplements for the treatment of the musculoskeletal system, namely, connective tissue diseases, cartilage injuries; herbal supplements for the treatment of the respiratory system; mineral supplements; amino acid dietary supplements; beta carotene supplements; calcium supplements; dietary supplements for general health and well-being; dietary supplements for promoting weight loss; herbal supplements for the treatment of arthritis; herbal supplements for the treatment of infectious diseases, namely, urinary tract infections; nutritional supplements for general health and wellbeing; homeopathic remedies for the treatment of colds and flu; homeopathic remedies for the treatment of headaches; antioxidant pills; homeopathic remedies for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; mineral salts for medical purposes; folic acid; flaxseed dietary supplements; flaxseed for use as a dietary supplement; medicines for alleviating constipation; diarrhea medication; intestinal disorder medicine for the treatment of intestinal bacteria and parasites; preparations for destroying parasites; intestinal disorder medicine for the treatment of irritable bowel syndrome; dietary fiber to aid digestion; gastrointestinal cleaning agents; intestinal disorder medicine for the treatment of ulcerative colitis; anti-viral agents; nail fungus treatment preparations; fungal medications; allergy medications; nasal drops for the treatment of allergies; ginseng capsules for general health and well-being; anti-cancer preparations; anti-inflammatories; anti-inflammatory ointments; anti-inflammatory preparations; anti-insect spray; anti-tussive expectorants; medicines for the treatment of gastrointestinal diseases; eye drops; iodine; ginkgo biloba; fennel for medical purposes; minerals for medical purposes; muscle relaxants; St. John's wort; pain relief medication; diuretics; lipotropic factor preparations; methionine preparations; medicines for adjusting the menstrual cycle; antiallergic medicines; nose drops; sleeping pills; preparations for the treatment of burns; acne medications; cough remedy; cough treatment medications; preparations for the treatment of asthma; herbal supplements for use in dermatology, namely, dermatitis, eczema, psoriasis; homeopathic remedies for treatment of skin conditions, namely, dermatitis, eczema, psoriasis; anti-inflammatory and antipyretic preparations; antipyretic preparations; antacids; anthelmintics; anti-dermoinfectives; anti-infectives; antiallergics; antidepressants; antifungal creams for medical use; antihistamines; antihypertensives; antimicrobials for dermatologic use; antiparasitic preparations; antiparasitics; antipyretic analgesics; antispasmodics; antitussives; antivirals; biological fungicides; botanical extracts for use in the treatment of dermatitis and skin pigmentation diseases; bronchodilating preparations; decongestants; diet pills and capsules; evening primrose oil; expectorants; fertility enhancement preparations for human use; fungicides; fungicides for medical use; herbal supplements for the treatment of cancer; herbal supplements for the treatment of dental and oral diseases; herbal supplements for use in oncology; homeopathic remedies for the treatment of dental and oral diseases; homeopathic remedies for the treatment of stomach ulcers; insect repellents; insect-repellents; intestinal disorder medicine for the treatment of diverticular disease; laxatives; lecithin for use as a dietary supplement; lysine preparations; menthol for medical purposes; mosquito repellents; mugwort dietary supplements; multivitamins; nasal spray preparations; ophthalmic preparations; psychotropics; sedatives; threonine preparations; vaginal antifungal preparations; virucidesACTIVE—
010Cupping glasses for moxibustion therapy; high frequency electromagnetic therapy apparatus; medical instruments for moxibustion therapyACTIVE—
030Beverages made of tea; green tea; herbal tea beverages; herbal teas; instant tea; non-alcoholic tea-based beverages; tea; tea extracts; turmeric for food; chamomile; cinnamon; black tea; chai tea; chamomile-based beverages; flavourings of tea; Japanese green tea; jasmine tea; tea substitutesACTIVE—
031Live plants, namely fenugreek; bran; live plants, namely, echinacea; unprocessed algae for human consumption; unprocessed hops; unprocessed wild hops; unprocessed bilberry; live plants, namely, hyssop; live plants, namely, bearberry shrubs; live plants, namely, black cohosh; live plants, namely, chicory roots; live plants, namely, juniper berries; unprocessed kola nutsACTIVE—
041Organization of alternative medicine exhibition for educational purposes; organization of seminars, working groups, research groups and conventions, in the field of medicine; organization of conferences and symposia in the field of medical scienceACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 5, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 17, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 17, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 17, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 17, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 17, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 5, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 31, 2020DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Mar 31, 2020ICNANOTICE OF ALLOWANCE CORRECTION ENTERED—
Mar 31, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 9, 2020IUCNNOTICE OF ALLOWANCE CANCELLED—
Mar 9, 2020D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Mar 9, 2020EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Mar 5, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 5, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 5, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 5, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 5, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 5, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 15, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 19, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 19, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 20, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 20, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 31, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 16, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 16, 2019DMCCDATA MODIFICATION COMPLETED—
Jul 16, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 15, 2019ALIEASSIGNED TO LIE—
Jul 12, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 11, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 11, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
May 28, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 28, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 19, 2019GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Feb 19, 2019GNSIINQUIRY TO SUSPENSION E-MAILED—
Feb 19, 2019CNSISUSPENSION INQUIRY WRITTEN—
Aug 16, 2018GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 16, 2018GNSLLETTER OF SUSPENSION E-MAILED—
Aug 16, 2018CNSLSUSPENSION LETTER WRITTEN—
Aug 14, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 13, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 13, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 15, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 15, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 15, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2018DOCKASSIGNED TO EXAMINER—
Jan 18, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 6, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance